It is unclear whether the occurrence and frequency of neoantigens impact already exhausted tumor-infiltrating T cells (TILs), although neo-antigen-specific CD8+ T cells have been identified by PD-1 expression (113). The gene discussed is CD8A; the disease is neoplasm.